State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer

State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer

Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the understanding of castration-resistant PrCa which has led to the development of new drugs that have an impact on patient survival. This review summarises t...

Full description

Bibliographic Details
Main Authors: Elena Castro, Nuria Romero, David Olmos
Format: Article
Language:English
Published: European Medical Journal 2014-11-01
Series:European Medical Journal Oncology
Subjects:
Bladder Cancer
Renal Cancer
testicular cancer
treatment options
Online Access:http://emjreviews.com/wp-content/uploads/State-Of-The-Art-Treatment-in-Castration-Resistant-Prostate-Cancer.pdf
id doaj-b5bbc90b02dd445ea2a3787c7eb5bf61
record_format Article
spelling doaj-b5bbc90b02dd445ea2a3787c7eb5bf612020-11-24T23:00:16ZengEuropean Medical JournalEuropean Medical Journal Oncology2054-619X2014-11-0121100105State-Of-The-Art Treatment in Castration-Resistant Prostate CancerElena Castro0Nuria Romero1David Olmos2Prostate Cancer and Genitourinary Tumours Unit, Clinical Research Programme, Spanish National Cancer Research Centre, Madrid, Spain. Prostate cancer unit, Clara Campal Comprehensive Cancer Center, HM Universitario Sanchinarro, Madrid, SpainProstate Cancer and Genitourinary Tumours Unit, Clinical Research Programme, Spanish National Cancer Research Centre, Madrid, Spain. Prostate cancer unit, Clara Campal Comprehensive Cancer Center, HM Universitario Sanchinarro, Madrid, SpainProstate Cancer and Genitourinary Tumours Unit, Clinical Research Programme, Spanish National Cancer Research Centre, Madrid, Spain. Prostate cancer unit, Clara Campal Comprehensive Cancer Center, HM Universitario Sanchinarro, Madrid, SpainProstate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the understanding of castration-resistant PrCa which has led to the development of new drugs that have an impact on patient survival. This review summarises the recent advances in the management of the disease. http://emjreviews.com/wp-content/uploads/State-Of-The-Art-Treatment-in-Castration-Resistant-Prostate-Cancer.pdfBladder CancerRenal Cancertesticular cancertreatment options
collection DOAJ
language English
format Article
sources DOAJ
author Elena Castro
Nuria Romero
David Olmos
spellingShingle Elena Castro
Nuria Romero
David Olmos
State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
European Medical Journal Oncology
Bladder Cancer
Renal Cancer
testicular cancer
treatment options
author_facet Elena Castro
Nuria Romero
David Olmos
author_sort Elena Castro
title State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
title_short State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
title_full State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
title_fullStr State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
title_full_unstemmed State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
title_sort state-of-the-art treatment in castration-resistant prostate cancer
publisher European Medical Journal
series European Medical Journal Oncology
issn 2054-619X
publishDate 2014-11-01
description Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the understanding of castration-resistant PrCa which has led to the development of new drugs that have an impact on patient survival. This review summarises the recent advances in the management of the disease.
topic Bladder Cancer
Renal Cancer
testicular cancer
treatment options
url http://emjreviews.com/wp-content/uploads/State-Of-The-Art-Treatment-in-Castration-Resistant-Prostate-Cancer.pdf
work_keys_str_mv AT elenacastro stateofthearttreatmentincastrationresistantprostatecancer
AT nuriaromero stateofthearttreatmentincastrationresistantprostatecancer
AT davidolmos stateofthearttreatmentincastrationresistantprostatecancer
_version_ 1725642719224659968

Similar Items